Charlotte, N.C., March 14, 2018 -- Opioid abuse statistics are staggering. More people die in the state of North Carolina of an accidental drug overdose, typically opioid-related, than any other cause of accidental death. [1] Public awareness of the opioid epidemic in America has steadily grown over the past year through media attention. Little has been done to date within the medical community to specifically answer how to prevent future opioid abuse at the initial encounter.
|
|||
OrthoCarolina physicians and the OrthoCarolina Research Institute (OCRI) are creating and implementing the Carolinas Opioid Reduction Effort (CORE) project, the nation’s first comprehensive study designed to assess the effectiveness of opioid-free pain management for patients. The study, launching this month, will include hundreds of patients from common surgeries across various orthopedic subspecialities. This groundbreaking research project seeks to identify safe, effective opioid-free alternative pain management options, eventually offering the national medical community a new protocol for future patient care.
A recent study performed at the OrthoCarolina Shoulder and Elbow Center on patients undergoing shoulder replacement surgery found that patients were safely and effectively treated with a novel, opioid free pain management regimen when compared to patients that were treated with opioid medications. This pivotal study has laid the ground work for future opportunities to offer patients effective alternatives to opioid medications.
In a recent interview, OrthoCarolina’s Nady Hamid, MD cites powerful data from the Center for Disease Control and Prevention: “In the United States, more patients are dying from substance abuse every year than from car accidents.”
North Carolina Attorney General Josh Stein has been vocal in his fight to combat the growing opioid epidemic in the state and is a supporter of the CORE Research Study. “Opioid painkillers are highly addictive; the CDC reports that one of five patients who take 10 days of opioids will still be taking them 12 months later,” he said. “And they are often not the most effective way to treat pain, as OrthoCarolina's preliminary findings suggest. I’m encouraged by OrthoCarolina's work to find non-addictive ways to treat pain, and I look forward to hearing about the results of its larger study.”
In support of the societally important and monumental endeavor of this timely study, The Duke Endowment has awarded OCRI with a multi-year research grant to help support this critical healthcare initiative. Based in Charlotte and established in 1924 by industrialist and philanthropist James B. Duke, The Duke Endowment is a private foundation that strengthens communities in North Carolina and South Carolina by nurturing children, promoting health, educating minds and enriching spirits. Since its founding, it has distributed more than $3.4 billion in grants. The Endowment shares a name with Duke University and Duke Energy, but all are separate organizations.
About OrthoCarolina
With expert physicians and care providers in locations throughout our region, OrthoCarolina is one of the nation’s leading orthopedic practices and your destination for comprehensive orthopedic care. Our expertise in the areas of foot and ankle, hand, hip and knee, shoulder and elbow, spine, sports medicine and pediatrics to offer a continuum of care unmatched in our region — and throughout the country.
OrthoCarolina. You. Improved.
Connect with OrthoCarolina at orthocarolina.com or on Facebook, Twitter and YouTube.
[1]North Carolina Department of Justice, Confronting North Carolina’s Opioid Crisis, [Web]. Retrieved from http://www.ncdoj.gov/opioidcrisis.
###
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0b578122-971f-436c-967c-bee1ade2f3b6
Logan Stewart OrthoCarolina 7043232486 [email protected]


DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 



